Advisory Board

 

Dario Neri, Founder, Philogen; Professor of Chemistry and Applied Biology, Swiss Federal Institute of Technology Zurich Dario Neri Founder, Philogen; Professor of Chemistry and Applied Biology, Swiss Federal Institute of Technology Zurich

Roy Baynes, SVP and Head Global Clinical Development, Chief Medical Officer, Merck, Sharp & Dohme (MSD) Roy Baynes
SVP and Head Global Clinical Development, Chief Medical Officer
Merck, Sharp & Dohme (MSD)

M. Anthony Moody, Associate Professor, Department of Paediatrics, Division of Infectious Diseases, Duke University Medical Centre M. Anthony Moody
Associate Professor, Department of Paediatrics, Division of Infectious Diseases
Duke University Medical Centre

Frédéric Triebel, Chief Scientific Officer, Chief Medical Officer, Prima BioMed Frédéric Triebel
Chief Scientific Officer, Chief Medical Officer Prima BioMed

Shane Olwill, Head of Immuno-Oncology, Pieris Pharmaceuticals Shane Olwill
Head of Immuno-Oncology
Pieris Pharmaceuticals

Alain Vertes, Managing Director, NxR Biotechnologies Alain Vertes
Managing Director
NxR Biotechnologies

Joern Schmitz, Head, Department of Immunotherapy, Fraunhofer IME Joern Schmitz
Head, Department of Immunotherapy
Fraunhofer IME

 

JOIN THE ADVISORY BOARD

 

Co-located with 

Part of


World Immunotherapy Congress 29-31 October, Basel, Switzerland

Part of the  Festival of Biologics

Sign Up for Event Updates